// App-Quantinova.ai

5332 : Prostate cancer targeting therapy using PSA promoter-driven perforin expression vector encapsulated in liposomes conjugated with anti-PSMA antibody

Researchers

Presenter

  • Kosuke Mizutani

Principal Investigators

  • Kyojiro Kawakami

  • Yasunori Fujita

  • Taku Kato

  • Manabu Takai

  • Daiki Kato

  • Koji Iinuma

  • Takuya Koie

  • Masafumi Ito

Medical Centers

  • Central Japan International Medical Center, Minokamo, Japan

  • Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.

  • Gifu University Hospital, Gifu, Japan

  • Osaka University Graduate School of Medicine, Suita, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • Prostate cancer

Biomarkers

  • Perforin 1

  • Peripheral blood mononuclear cell

  • Prostate specific antigen

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved